Article
Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.
Clinical and vaccine immunology : CVI - 1 Jul 2011
Thiele Sonja, Borschewski Aljona, Küchler Judit, Bieberbach Marc, Voigt Sebastian, Ehlers Bernhard
Abstract excerpt
To prevent complications that might follow an infection with varicella-zoster virus (VZV), the live attenuated Oka strain (V-Oka) is administered to children in many developed countries. Three vaccine brands (Varivax from Sanofi Pasteur MSD; Varilrix and Priorix-Tetra, both from Glaxo-Smith-Kline) are licensed in Germany and have been associated with both different degrees of vaccine effectiveness and adverse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
